Related references
Note: Only part of the references are listed.GSK3β suppression inhibits MCL1 protein synthesis in human acute myeloid leukemia cells
Yuan-Chin Lee et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
PROTACs to address the challenges facing small molecule inhibitors
Pedro Martin-Acosta et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
FBW7 Inhibits Myeloid Differentiation in Acute Myeloid Leukemia via GSK3-Dependent Ubiquitination of PU.1
Mukul Mishra et al.
MOLECULAR CANCER RESEARCH (2021)
PU.1 subcellular localization in acute myeloid leukaemia with mutated NPM1
Giulia Pianigiani et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Emerging roles of GSK-3α in pathophysiology: Emphasis on cardiometabolic disorders
Firdos Ahmad et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)
A User's Guide to Novel Therapies for Acute Myeloid Leukemia
Shyam A. Patel et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)
Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
Youn-Sang Jung et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
The Role Played by Wnt/beta-Catenin Signaling Pathway in Acute Lymphoblastic Leukemia
Francesca Chiarini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Targeting Wnt/β-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia
Cecilia Evangelisti et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancer
Camilla Evangelisti et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)
Phase I Trial of Lithium and Tretinoin for Treatment of Relapsed and Refractory Non-promyelocytic Acute Myeloid Leukemia
Masumi Ueda et al.
FRONTIERS IN ONCOLOGY (2020)
Improving the Treatment of Acute Lymphoblastic Leukemia
Ashish Radadiya et al.
BIOCHEMISTRY (2020)
FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets
Reem Saleh et al.
CANCER LETTERS (2020)
Wnt Signaling in Leukemia and Its Bone Marrow Microenvironment
Yongsheng Ruan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Small Molecule Inhibitors of Microenvironmental Wnt/β-Catenin Signaling Enhance the Chemosensitivity of Acute Myeloid Leukemia
Paul Takam Kamga et al.
CANCERS (2020)
Targeting transcription factors in acute myeloid leukemia
Hisashi Takei et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2019)
Glycogen synthase kinases: Moonlighting proteins with theranostic potential in cancer
Siddavaram Nagini et al.
SEMINARS IN CANCER BIOLOGY (2019)
HAP1 loss confers L-asparaginase resistance in ALL by downregulating the calpain-1-Bid-caspase-3/12 pathway
Jung Kwon Lee et al.
BLOOD (2019)
Synthetic Lethality of Wnt Pathway Activation and Asparaginase in Drug-Resistant Acute Leukemias
Laura Hinze et al.
CANCER CELL (2019)
WNT Signaling in Cancer Immunosurveillance
Lorenzo Galluzzi et al.
TRENDS IN CELL BIOLOGY (2019)
NDRG2 Sensitizes Myeloid Leukemia to Arsenic Trioxide via GSK3-NDRG2-PP2A Complex Formation
Soojong Park et al.
CELLS (2019)
Discovery of novel glycogen synthase kinase-3α inhibitors: Structure-based virtual screening, preliminary SAR and biological evaluation for treatment of acute myeloid leukemia
Yanxing Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Efficacy and Safety of Glycogen Synthase Kinase 3 Inhibitors for Alzheimer's Disease: A Systematic Review and Meta-Analysis
Shinji Matsunaga et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Regulation of GSK3 cellular location by FRAT modulates mTORC1-dependent cell growth and sensitivity to rapamycin
Long He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
In Vitro Expansion of Hematopoietic Stem Cells by Inhibition of Both GSK3 and p38 Signaling
Jing Li et al.
STEM CELLS AND DEVELOPMENT (2019)
Pyrrothiogatain acts as an inhibitor of GATA family proteins and inhibits Th2 cell differentiation in vitro
Shunsuke Nomura et al.
SCIENTIFIC REPORTS (2019)
Molecularly distinct models of zebrafish Myc-induced B cell leukemia
Chiara Borga et al.
LEUKEMIA (2019)
Signaling Enzymes Required for Sperm Maturation and Fertilization in Mammals
Souvik Dey et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Acute Promyelocytic Leukemia: A History over 60 Years-From the Most Malignant to the most Curable Form of Acute Leukemia
Xavier Thomas
ONCOLOGY AND THERAPY (2019)
Loss of protein phosphatase 2A regulatory subunit B56 delta promotes spontaneous tumorigenesis in vivo
C. Lambrecht et al.
ONCOGENE (2018)
A partnership with the proteasome; the destructive nature of GSK3
Holly Robertson et al.
BIOCHEMICAL PHARMACOLOGY (2018)
T cell acute lymphoblastic leukemia (T-ALL): New insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies
Eduardo Vadillo et al.
BLOOD REVIEWS (2018)
mTORC1 Promotes Metabolic Reprogramming by the Suppression of GSK3-Dependent Foxk1 Phosphorylation
Long He et al.
MOLECULAR CELL (2018)
Exploiting an Asp-Glu switch in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia
Florence F. Wagner et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate Randomization
Stuart S. Winter et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Revisiting the Concept of Targeting NFAT to Control T Cell Immunity and Autoimmune Diseases
Jae-Ung Lee et al.
FRONTIERS IN IMMUNOLOGY (2018)
Aberrant GSK3β nuclear localization promotes AML growth and drug resistance
James J. Ignatz-Hoover et al.
BLOOD ADVANCES (2018)
Pharmacological inhibition of the transcription factor PU.1 in leukemia
Ileana Antony-Debre et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Protein tyrosine phosphatase SHP-1 modulates osteoblast differentiation through direct association with and dephosphorylation of GSK3β
Xiao-Lu Tang et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
The Key Roles of GSK-3 beta in Regulating Mitochondrial Activity
Kai Yang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
How should we treat a patient with relapsed Ph-negative B-ALL and what novel approaches are being investigated?
Nicola Goekbuget
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2017)
A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220
Panpan Hou et al.
CANCER RESEARCH (2017)
Mcl-1 Degradation Is Required for Targeted Therapeutics to Eradicate Colon Cancer Cells
Jingshan Tong et al.
CANCER RESEARCH (2017)
Calcineurin and GSK-3 inhibition sensitizes T-cell acute lymphoblastic leukemia cells to apoptosis through X-linked inhibitor of apoptosis protein degradation
V. Tosello et al.
LEUKEMIA (2016)
Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer
James A. McCubrey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Update on rational targeted therapy in AML
Danielle Shafer et al.
BLOOD REVIEWS (2016)
GSK3 Deficiencies in Hematopoietic Stem Cells Initiate Pre-neoplastic State that Is Predictive of Clinical Outcomes of Human Acute Leukemia
Borhane Guezguez et al.
CANCER CELL (2016)
GSK-3 Inhibition Sensitizes Acute Myeloid Leukemia Cells to 1,25D-Mediated Differentiation
Kalpana Gupta et al.
CANCER RESEARCH (2016)
An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia
David A. Rizzieri et al.
LEUKEMIA & LYMPHOMA (2016)
A Novel Glycogen Synthase Kinase-3 Inhibitor Optimized for Acute Myeloid Leukemia Differentiation Activity
Sophia Hu et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Negative regulation of NF-κB p65 activity by serine 536 phosphorylation
Jean-Philippe Pradere et al.
SCIENCE SIGNALING (2016)
Repression of GSK3 restores NK cell cytotoxicity in AML patients
Reshmi Parameswaran et al.
NATURE COMMUNICATIONS (2016)
T-cell acute lymphoblastic leukemia
Elizabeth A. Raetz et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2016)
Negative regulation of NF-κB p65 activity by serine 536 phosphorylation
Jean-Philippe Pradere et al.
SCIENCE SIGNALING (2016)
A first-in-human phase I dose-escalation, pharmacokinetic, and pharmacodynamic evaluation of intravenous LY2090314, a glycogen synthase kinase 3 inhibitor, administered in combination with pemetrexed and carboplatin
Jhanelle E. Gray et al.
INVESTIGATIONAL NEW DRUGS (2015)
Galectin-3 mediates bone marrow microenvironment-induced drug resistance in acute leukemia cells via Wnt/β-catenin signaling pathway
Kaimin Hu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
Evaluation of Improved Glycogen Synthase Kinase-3α Inhibitors in Models of Acute Myeloid Leukemia
Theresa Neumann et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Lithium chloride antileukemic activity in acute promyelocytic leukemia is GSK-3 and MEK/ERK dependent
F. Zassadowski et al.
LEUKEMIA (2015)
Tetramethylpyrazine inhibits the proliferation of acute lymphocytic leukemia cell lines via decrease in GSK-3β
Xiao-Jing Wang et al.
ONCOLOGY REPORTS (2015)
Phosphorylation of GSK3α/β correlates with activation of AKT and is prognostic for poor overall survival in acute myeloid leukemia patients
Peter P. Ruvolo et al.
BBA CLINICAL (2015)
Glycogen Synthase Kinase-3β Stabilizes the Interleukin (IL)-22 Receptor from Proteasomal Degradation in Murine Lung Epithelia
Nathaniel M. Weathington et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Multifaceted roles of GSK-3 and Wnt/beta-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention
J. A. McCubrey et al.
LEUKEMIA (2014)
A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy
Eduardo Tolosa et al.
MOVEMENT DISORDERS (2014)
Glycogen synthase kinase-3β positively regulates protein synthesis and cell proliferation through the regulation of translation initiation factor 4E-binding protein 1
S. Shin et al.
ONCOGENE (2014)
Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo
Anna Goc et al.
ONCOTARGET (2014)
Activator or inhibitor? GSK-3 as a new drug target
Fumi Takahashi-Yanaga
BIOCHEMICAL PHARMACOLOGY (2013)
Treatment of Alzheimer's Disease with the GSK-3 Inhibitor Tideglusib: A Pilot Study
Teodoro del Ser et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
The beta-Catenin Destruction Complex
Jennifer L. Stamos et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
GSK-3 and mitochondria in cancer cells
Federica Chiara et al.
FRONTIERS IN ONCOLOGY (2013)
GSK-3α and GSK-3β Proteins Are Involved in Early Stages of Chondrocyte Differentiation with Functional Redundancy through RelA Protein Phosphorylation
Shozo Itoh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia
Versha Banerji et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group
Stephen P. Hunger et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Wnt signaling strength regulates normal hematopoiesis and its deregulation is involved in leukemia development
T. C. Luis et al.
LEUKEMIA (2012)
GSK3 is a regulator of RAR-mediated differentiation
K. Gupta et al.
LEUKEMIA (2012)
Maintenance of hematopoietic stem cells through regulation of Wnt and mTOR pathways
Jian Huang et al.
NATURE MEDICINE (2012)
GSK3 as a sensor determining cell fate in the brain
Adam R. Cole
FRONTIERS IN MOLECULAR NEUROSCIENCE (2012)
GSK3β inactivation induces apoptosis of leukemia cells by repressing the function of c-Myb
Fangfang Zhou et al.
MOLECULAR BIOLOGY OF THE CELL (2011)
GSK3 inhibitors enhance retinoic acid receptor activity and induce the differentiation of retinoic acid-sensitive myeloid leukemia cells
J. Si et al.
LEUKEMIA (2011)
Glycogen synthase kinase (GSK)-3 promotes p70 ribosomal protein S6 kinase (p70S6K) activity and cell proliferation
Sejeong Shin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
GSK-3: functional insights from cell biology and animal models
Oksana Kaidanovich-Beilin et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2011)
Characterization of a GSK-3 inhibitor in culture of human cord blood primitive hematopoietic cells
Junfen Jiang et al.
BIOMEDICINE & PHARMACOTHERAPY (2010)
Glycogen synthase kinase-3β inhibitors suppress leukemia cell growth
Emma Y. Song et al.
EXPERIMENTAL HEMATOLOGY (2010)
Suppressive Regulatory T Cell Activity Is Potentiated by Glycogen Synthase Kinase 3β Inhibition
Jay A. Graham et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Glycogen synthase kinase-3β inhibition induces nuclear factor-κB-mediated apoptosis in pediatric acute lymphocyte leukemia cells
Yanni Hu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Subcellular Localization of Glycogen Synthase Kinase 3β Controls Embryonic Stem Cell Self-Renewal
Matthew Bechard et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Deletion of GSK-3β in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation
Risto Kerkela et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy
Zhong Wang et al.
NATURE (2008)
Glycogen synthase kinase-3β inhibition preserves hematopoietic stem cell activity and inhibits leukemic cell growth
Tiffany Holmes et al.
STEM CELLS (2008)
Functional redundancy of GSK-3α and GSK-3β in Wnt/β-catenin signaling shown by using an allelic series of embryonic stem cell lines
Bradley W. Doble et al.
DEVELOPMENTAL CELL (2007)
Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells
K Ito et al.
NATURE MEDICINE (2006)
Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation
JJ Trowbridge et al.
NATURE MEDICINE (2006)
Glycogen synthase kinase-3β is tyrosine-phosphorylated by MEK1 in human skin fibroblasts
F Takahashi-Yanaga et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1
F Rosenbauer et al.
NATURE GENETICS (2004)
Synthetic small molecules that control stem cell fate
S Ding et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Structural basis for recruitment of glycogen synthase kinase 3β to the axin-APC scaffold complex
R Dajani et al.
EMBO JOURNAL (2003)
Expression, localization, and activity of glycogen synthase kinase 3β during mouse skin tumorigenesis
H Leis et al.
MOLECULAR CARCINOGENESIS (2002)
Regulation of glycogen synthesis in human muscle cells
SJ Yeaman et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2001)
Crystal structure of glycogen synthase kinase 3β:: Structural basis for phosphate-primed substrate specificity and autoinhibition
R Dajani et al.
CELL (2001)
Share Paper
